- Alternative Medicine
- Mesothelioma Cure
- Mesothelioma Research
- Mesothelioma Doctors
- Mesothelioma Cancer Centers
- Mesothelioma Clinical Trials
Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Dr. John P Hoffman
In 1970, Dr. John P. Hoffman graduated with a medical degree from Case Western Reserve School of Medicine in Cleveland, Ohio. Following graduation, he completed his residency requirements in general surgery at the Virginia Mason Hospital in Seattle, Washington. Later, Dr. Hoffman completed a fellowship in surgical oncology at Memorial Sloan-Kettering Cancer Center. After completing his residency, he remained on staff for an additional year to study pancreatic and liver surgery. The Memorial Sloan-Kettering Cancer Center is recognized as a leading cancer center in New York. After becoming board-certified, Dr. Hoffman was appointed the Director of Surgical Oncology at Loyola University School of Medicine in Illinois.
Dr. Hoffman holds a number of memberships and has won several awards for his service and cancer-related research. In 2009, he was featured in the Philadelphia Magazine as one of the best surgeons in the region. He is also a member of the American Society of Clinical Oncology and the American College of Surgeons.
Dr. Hoffman contributes to the research community by writing journals and scientific reports on cancer treatment options. Many of his publications have appeared in American Surgeon and the American Journal of Clinical Oncology.
Dr. Hoffman is a leader in his field. He and his colleagues have successfully pioneered several procedures. For example, he was on the team that completed a splenectomy, gastroectomy, and gastrointestinal reconstruction laparascopically.
Currently, Dr. Hoffman is serving as the Chief of Pancreaticobiliary Surgery at the Fox Chase Cancer Center in Philadelphia, Pennsylvania. He has held this position since 1986. Dr. Hoffman specializes in gastrointestinal, liver, pancreatic and breast cancers. He also participates in clinical trials for peritoneal mesothelioma and other types of cancers as well. Dr. Hoffman has recognized the need to develop more effective treatments for mesothelioma and is pursuing these efforts. Though, most of his work is focused on pancreatic cancer, he remains abreast of the latest developments in mesothelioma.
Because of the long latency period, patients diagnosed with mesothelioma often are in the later stages of cancer development. Asbestos may remain dormant in the body for 20 years or more before cancer develops, if at all. However, oncologists such as Dr. Hoffman are working daily to find both diagnostic techniques that will catch the cancer earlier, and effective treatments toextend the lives of mesothelioma patients.